Third Rock Ventures VI, L.P.
10% owner at Rapport Therapeutics.
- Rank
- 536th of 813
- Companies held
- 1
- Largest holding
- RAPP, 100.0% of total
- Latest SEC filing
- May 8, 2026
- Listed but not counted
- $22.9M
What the $152M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Rapport Therapeutics RAPP Common Stock | Directly | 6,432,715 | $23.59 | $152M | 100.0% | Form 4, May 8, 2026 |
Share counts are the amounts Third Rock Ventures VI, L.P. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Third Rock Ventures VI, L.P.'s filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Rapport Therapeutics RAPP Common Stock | Through Third Rock Ventures VI, L.P. Held by a company or fund the insider manages | 969,218 | $23.59 | $22.9M | — | Form 4, May 7, 2026 |
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 533 | RC IV Cayman ICW Equity LLC Insider, Driven Brands Holdings | $152M |
| 534 | Honeywell International INC 10% owner, Quantinuum | $152M |
| 535 | Casdin Partners FO1-MSV, LP 10% owner, GeneDx Holdings | $152M |
| 536 | Third Rock Ventures VI, L.P. 10% owner, Rapport Therapeutics | $152M |
| 537 | General Catalyst Group VIII Supplemental, L.P. 10% owner, Samsara | $151M |
| 538 | Siddhi Sponsor LLC 10% owner, Siddhi Acquisition | $150M |
| 539 | Sequoia Capital Usv Xiv Holdco, Ltd. 10% owner, DoorDash | $150M |
Other Rapport Therapeutics insiders
All RAPP insiders- Steven M. Paul$13.1MDirector. #3875 overall
- Abraham Ceesay$13.0MChief Executive Officer. #6744 overall
- David Bredt$9.3MChief Scientific Officer. #9295 overall
- John Maraganore$222KDirector. #1983 overall
Questions
How much stock does Third Rock Ventures VI, L.P. own?
Third Rock Ventures VI, L.P. holds $151,747,747 in listed stock based on SEC filings and current prices, mostly Rapport Therapeutics (RAPP). That ranks 536th on the Stock Rich List.
Is this Third Rock Ventures VI, L.P.'s net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Third Rock Ventures VI, L.P. last buy or sell stock?
The most recent open-market trade on file is a sale of 5,018 RAPP shares on May 8, 2026 at $40.31.